Index of reports
> Cases with Vomiting (177)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Xeloda (Capecitabine) where reactions include vomiting. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 177 Next >>
Possible Xeloda side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male, weighing 101.7 kg (223.7 pounds)
Reactions: Death, Fatigue, Vomiting
Adverse event resulted in: death
Drug(s) suspected as cause:
Xeloda
Xeloda
Administration route: Oral
Indication: Bile Duct Cancer
Start date: 2012-02-06
Other drugs received by patient: Prochlorperazine; Prochlorperazine
Possible Xeloda side effects in female
Reported by a consumer/non-health professional from Mexico on 2012-08-27
Patient: female, weighing 43.0 kg (94.6 pounds)
Reactions: Thrombosis, Vomiting, Monoplegia, Nausea, Diarrhoea, Oedema Peripheral, Headache
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in female
Reported by a physician from Switzerland on 2012-08-22
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Abdominal Pain, Vomiting, Anaemia, Lymphopenia, Pyrexia, Diarrhoea, Small Intestinal Perforation, Sepsis, Hypoalbuminaemia, Neutropenia, Enterocolitis, Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Xeloda
Other drugs received by patient: Herceptin
Possible Xeloda side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22
Patient: male, weighing 89.9 kg (197.8 pounds)
Reactions: Vomiting, Dyspnoea, Nausea, Dehydration, Pneumomediastinum, Pneumothorax, Odynophagia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Oesophageal Cancer Metastatic
Start date: 2011-05-17
End date: 2011-11-15
Avastin
Dosage: last dose recieved on 14 feb 2012
End date: 2012-02-14
Herceptin
Dosage: last dose recieved on 14 feb 2012.
End date: 2012-02-14
Herceptin
Dosage: last dose recieved on 14 feb 2012.
Indication: Oesophageal Cancer Metastatic
Start date: 2011-05-10
End date: 2011-11-15
Oxaliplatin
Indication: Oesophageal Cancer Metastatic
Start date: 2011-05-17
End date: 2011-11-15
Oxaliplatin
End date: 2012-02-14
Xeloda
End date: 2012-02-26
Xeloda
Indication: Oesophageal Cancer Metastatic
Start date: 2011-05-17
End date: 2011-11-29
Other drugs received by patient: Actos; Lorazepam; DTO; Prilosec; Ritalin; Toprol-XL; Potassium Chloride; Lomotil; Dexamethasone; Compazine; Prednisone TAB; Citalopram Hydrobromide; Morphine Sulfate; Lisinopril; Metoprolol Tartrate; Dicyclomine; Methylphenidate; Zofran; Oxycodone HCL; Decadron Phosphate; Bentyl; Emend
Possible Xeloda side effects in
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-08-21
Patient:
Reactions: Proctitis, Vomiting, Diarrhoea, Nausea, Sepsis, Faecal Incontinence, Pulmonary Embolism, Cardiotoxicity, Thrombocytopenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Oxaliplatin
Dosage: days 1, 8, and 15
Indication: Rectal Cancer
Xeloda
Dosage: monday to friday
Indication: Rectal Cancer
Possible Xeloda side effects in 60 year old female
Reported by a physician from Canada on 2012-08-20
Patient: 60 year old female
Reactions: Vomiting, Nausea, Diarrhoea, Neoplasm Malignant, Dehydration, Disease Progression, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Tykerb
Administration route: Oral
Tykerb
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Xeloda
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Hydromorphone Hydrochloride; Retinol; Prevacid; Micardis; Verapamil HCL; Celebrex; Colace; Vitamin D; Antihypertensive Medications; Actonel; Senokot
Possible Xeloda side effects in 79 year old male
Reported by a consumer/non-health professional from China on 2012-08-20
Patient: 79 year old male
Reactions: Asthma, Productive Cough, Urinary Incontinence, Bronchial Carcinoma, Aphasia, Rash Pruritic, Off Label Use, Poor Quality Sleep, Death, Oedema Peripheral, Blood Creatinine Increased, Epistaxis, Decreased Appetite, Emphysema, Stomatitis, Vomiting, Pneumonia, Dyspnoea, Blood Urea Increased, Nausea, Rhinorrhoea, Rash, Diarrhoea, Cerebral Infarction, Depressed Level of Consciousness, Metastases To Bone, Asthenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: unk
Indication: Rectal Cancer Metastatic
Tarceva
Dosage: 150 mg, uid/qd
Administration route: Oral
Indication: Rectal Cancer Metastatic
Start date: 2012-06-01
End date: 2012-06-09
Xeloda
Dosage: 1.5 df, bid for 2 weeks followed by 7 day rest period
Administration route: Oral
Indication: Rectal Cancer Metastatic
End date: 2012-02-23
Possible Xeloda side effects in 79 year old male
Reported by a consumer/non-health professional from China on 2012-08-20
Patient: 79 year old male
Reactions: Productive Cough, Aphasia, Bronchial Carcinoma, Rash Pruritic, Poor Quality Sleep, Death, Incontinence, Oedema Peripheral, Blood Creatinine Increased, Epistaxis, Decreased Appetite, Emphysema, Dyspnoea, Blood Urea Increased, Stomatitis, Vomiting, Nausea, Rhinorrhoea, Diarrhoea, Cerebral Infarction, Depressed Level of Consciousness, Metastases To Bone, Asthenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Rectal Cancer Metastatic
Tarceva
Administration route: Oral
Indication: Rectal Cancer Metastatic
Start date: 2012-06-01
End date: 2012-06-09
Xeloda
Administration route: Oral
Indication: Rectal Cancer Metastatic
End date: 2012-02-23
Possible Xeloda side effects in female
Reported by a physician from Japan on 2012-08-16
Patient: female, weighing 44.0 kg (96.8 pounds)
Reactions: Vomiting, Dermatitis, Cerebral Vasoconstriction, Cerebral Infarction, Cerebrovascular Spasm
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Rectal Cancer Recurrent
Start date: 2012-05-21
End date: 2012-05-21
Xeloda
Administration route: Oral
Indication: Rectal Cancer Recurrent
Start date: 2012-05-21
End date: 2012-05-23
Other drugs received by patient: Oxycontin; Celebrex; Oxaliplatin; Hochuekkito
Possible Xeloda side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-14
Patient: male, weighing 55.4 kg (121.9 pounds)
Reactions: Back Pain, Vomiting, Nausea, Musculoskeletal Pain, Abasia, Pain, Ill-Defined Disorder, Malaise, Fatigue, Ageusia, Diarrhoea, Gait Disturbance, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Administration route: Oral
Start date: 2012-05-24
End date: 2012-05-31
Xeloda
Administration route: Oral
Indication: Colon Cancer
Start date: 2012-05-07
End date: 2012-05-24
Xeloda
Administration route: Oral
Start date: 2012-06-02
End date: 2012-07-05
Other drugs received by patient: Oxaliplatin
Possible Xeloda side effects in female
Reported by a pharmacist from United States on 2012-08-09
Patient: female
Reactions: Vomiting, Dyspnoea, Renal Failure, Nausea, Drug Intolerance, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Other drugs received by patient: Compazine; Lovaza; Cardizem; Hydrochlorothiazide; Coq10; Lotemax; Oxycodone HCL; Levothyroxine Sodium; Fentanyl; Metformin; Vitamin D
Possible Xeloda side effects in female
Reported by a physician from Japan on 2012-08-08
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Incontinence, Vomiting, Disseminated Intravascular Coagulation, Acute Hepatic Failure, Altered State of Consciousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Meropenem
Dosage: dosage is uncertain.
Indication: Infection Prophylaxis
Start date: 2011-10-14
End date: 2011-10-18
Xeloda
Administration route: Oral
Indication: Rectal Cancer
Start date: 2011-08-29
End date: 2011-09-11
Xeloda
Administration route: Oral
Start date: 2011-09-26
End date: 2011-10-09
Other drugs received by patient: Ganaton; Aloxi; Famotidine; Oxaliplatin; Pydoxal; Dexamethasone Sodium Phosphate
Possible Xeloda side effects in 78 year old male
Reported by a consumer/non-health professional from China on 2012-08-07
Patient: 78 year old male
Reactions: Productive Cough, Asthma, Aphasia, Bronchial Carcinoma, Rash Pruritic, Death, Off Label Use, Incontinence, Oedema Peripheral, Blood Creatinine Increased, Epistaxis, Decreased Appetite, Stomatitis, Dyspnoea, Vomiting, Blood Urea Increased, Nausea, Diarrhoea, Insomnia, Depressed Level of Consciousness, Metastases To Bone, Asthenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: unk
Indication: Rectal Cancer Metastatic
Tarceva
Dosage: 150 mg, uid/qd
Administration route: Oral
Indication: Rectal Cancer Metastatic
Start date: 2012-06-01
End date: 2012-06-09
Xeloda
Dosage: 1.5 df, bid for 2 weeks followed by 7 day rest period
Administration route: Oral
Indication: Rectal Cancer Metastatic
End date: 2012-02-23
Possible Xeloda side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient: female
Reactions: Death, Vomiting, Oedema Peripheral, Insomnia, Asthenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-08-06
Patient:
Reactions: Vomiting, Anaemia, Pulmonary Embolism, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Peripheral Sensory Neuropathy, Mucosal Inflammation, Diarrhoea, Proteinuria, Neutropenia, Leukopenia
Drug(s) suspected as cause:
Avastin
Dosage: fluorouracil based regimen
Indication: Colorectal Cancer Metastatic
Avastin
Dosage: capecitabine-based regimen
Fluorouracil
Dosage: on day 1
Fluorouracil
Indication: Colorectal Cancer Metastatic
Irinotecan Hydrochloride
Dosage: dose: 150/180 mg/m2 on day 1
Indication: Colorectal Cancer Metastatic
Leucovorin Calcium
Dosage: on day 1
Indication: Colorectal Cancer Metastatic
Oxaliplatin
Dosage: on day 1
Indication: Colorectal Cancer Metastatic
Xeloda
Indication: Colorectal Cancer Metastatic
Possible Xeloda side effects in 78 year old male
Reported by a consumer/non-health professional from China on 2012-08-06
Patient: 78 year old male
Reactions: Productive Cough, Asthma, Aphasia, Bronchial Carcinoma, Rash Pruritic, Death, Incontinence, Oedema Peripheral, Blood Creatinine Increased, Decreased Appetite, Epistaxis, Vomiting, Stomatitis, Dyspnoea, Blood Urea Increased, Nausea, Diarrhoea, Depressed Level of Consciousness, Metastases To Bone, Asthenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Rectal Cancer Metastatic
Tarceva
Administration route: Oral
Indication: Rectal Cancer Metastatic
Start date: 2012-06-01
End date: 2012-06-09
Xeloda
Administration route: Oral
Indication: Rectal Cancer Metastatic
End date: 2012-02-23
Possible Xeloda side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-06
Patient: female
Reactions: Dyspnoea, Vomiting, Nausea, Headache, Pericardial Effusion, Dysgeusia, Diarrhoea, Chest Pain, Pulmonary Thrombosis, Decreased Appetite
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Tykerb
Indication: Breast Cancer
Start date: 2012-01-23
End date: 2012-07-01
Xeloda
Indication: Breast Cancer
Start date: 2012-01-23
End date: 2012-07-01
Possible Xeloda side effects in female
Reported by a physician from Germany on 2012-08-03
Patient: female, weighing 92.5 kg (203.5 pounds)
Reactions: Vomiting, Nausea, General Physical Health Deterioration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Breast Cancer
Start date: 2011-12-22
End date: 2012-06-21
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2011-12-22
End date: 2012-06-21
Other drugs received by patient: Xgeva
Possible Xeloda side effects in female
Reported by a physician from Japan on 2012-07-30
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Vomiting, Incontinence, Disseminated Intravascular Coagulation, Platelet Count Decreased, Acute Hepatic Failure, Neutropenia, Altered State of Consciousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Meropenem
Dosage: dosage is uncertain.
Indication: Infection Prophylaxis
Start date: 2011-10-14
End date: 2011-10-18
Xeloda
Administration route: Oral
Indication: Rectal Cancer
Start date: 2011-08-29
End date: 2011-09-11
Xeloda
Administration route: Oral
Start date: 2011-09-26
End date: 2011-10-09
Other drugs received by patient: Aloxi; Dexamethasone Sodium Phosphate; Ganaton; Oxaliplatin; Famotidine; Pydoxal
Possible Xeloda side effects in 51 year old female
Reported by a physician from Canada on 2012-07-30
Patient: 51 year old female
Reactions: Vomiting, Tongue Discolouration, Diarrhoea, Insomnia, Asthenia, Decreased Appetite
Drug(s) suspected as cause:
Tykerb
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Xeloda
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Norvasc; Prochlorperazine; Decadron; Docusate Sodium; Lactulose; Pantoprazole Sodium; Metformin Hydrochloride; Tylenol with Codeine #3 (United States)
Possible Xeloda side effects in female
Reported by a physician from United States on 2012-07-26
Patient: female, weighing 65.8 kg (144.8 pounds)
Reactions: Pneumonia, Vomiting, Diarrhoea, Nausea, Urinary Tract Infection, Intestinal Obstruction, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Other drugs received by patient: Revlimid
Possible Xeloda side effects in female
Reported by a physician from Germany on 2012-07-24
Patient: female, weighing 92.5 kg (203.5 pounds)
Reactions: Vomiting, Nausea, General Physical Health Deterioration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Breast Cancer
Start date: 2011-12-22
End date: 2012-06-21
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2011-12-22
End date: 2012-06-21
Other drugs received by patient: Xgeva
Possible Xeloda side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-20
Patient: female
Reactions: Confusional State, Vomiting, Adverse Drug Reaction, Constipation, Tremor
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in 48 year old male
Reported by a physician from Germany on 2012-07-20
Patient: 48 year old male
Reactions: Jaundice, Vomiting, Nausea, Neoplasm Malignant, Anaemia, Malignant Ascites, Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Oxaliplatin
Indication: Pancreatic Carcinoma Metastatic
Start date: 2009-07-01
End date: 2010-04-01
Tarceva
Indication: Pancreatic Carcinoma Metastatic
Start date: 2007-02-27
End date: 2009-07-15
Xeloda
Indication: Pancreatic Carcinoma Metastatic
Start date: 2009-07-01
End date: 2010-04-01
Other drugs received by patient: Gemcitabine; Granocyte
Possible Xeloda side effects in female
Reported by a pharmacist from United States on 2012-07-20
Patient: female
Reactions: Abdominal Pain, Haematochezia, Vomiting, Stomatitis, Diarrhoea, Dehydration, Dizziness
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in female
Reported by a physician from Germany on 2012-07-19
Patient: female
Reactions: Weight Decreased, Pulmonary Embolism, Pyrexia, Hyperhidrosis, Cardiac Disorder, Intestinal Perforation, Dyspepsia, Proteinuria, Epistaxis, Gingival Bleeding, Anaemia, Cardiomyopathy, Neutropenia, Hypersensitivity, Bone Pain, Pain, Chills, Skin Reaction, Abdominal Pain Upper, Polyneuropathy, Myalgia, Fatigue, Oedema, Dizziness, Myocardial Infarction, Nail Toxicity, Thrombocytopenia, Decreased Appetite, Vomiting, Dyspnoea, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Cerebrovascular Accident, Dysgeusia, Mucosal Inflammation, Anxiety, Diarrhoea, Impaired Healing, Arthralgia, Hypertension, Asthenia, Leukopenia
Drug(s) suspected as cause:
Avastin
Indication: Breast Cancer
Herceptin
Indication: Breast Cancer
Xeloda
Indication: Breast Cancer
Possible Xeloda side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-16
Patient: female
Reactions: Death, Breast Cancer Metastatic, Vomiting, Metastases To Liver, Metastases To Lung
Adverse event resulted in: death
Drug(s) suspected as cause:
Tykerb
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-08-11
End date: 2011-02-09
Xeloda
Indication: Product Used FOR Unknown Indication
Possible Xeloda side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-16
Patient: male, weighing 63.6 kg (139.8 pounds)
Reactions: Vomiting, Nausea, Diarrhoea, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in female
Reported by a physician from Germany on 2012-07-11
Patient: female, weighing 65.0 kg (143.0 pounds)
Reactions: Mucosal Inflammation, Vomiting, Nausea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in female
Reported by a physician from United States on 2012-07-11
Patient: female, weighing 31.8 kg (70.0 pounds)
Reactions: Weight Decreased, Abdominal Discomfort, Epistaxis, Product Counterfeit, Back Pain, Stomatitis, Wound Dehiscence, Pain in Extremity, Drug Intolerance, Toxicity To Various Agents, Paraesthesia, Eating Disorder, Tremor, Metastases To Spine, Skin Exfoliation, Abdominal Pain Upper, Death, Nephrolithiasis, Fatigue, Neuropathy Peripheral, Abdominal Distension, Decreased Appetite, Pain in JAW, White Blood Cell Count Decreased, Vomiting, Drug Hypersensitivity, Incorrect Dose Administered, Deformity, Skin Irritation, Ascites, Limb Deformity, Lung Disorder, Neoplasm Malignant, Flank Pain
Adverse event resulted in: death
Drug(s) suspected as cause:
Avastin
Avastin
Start date: 2008-12-18
End date: 2009-01-07
Avastin
Indication: Colorectal Cancer Metastatic
Avastin
Start date: 2007-08-01
End date: 2007-09-01
Avastin
Start date: 2009-01-28
End date: 2009-05-13
Avastin
Avastin
Avastin
Start date: 2009-05-27
End date: 2009-09-01
Fluorouracil
Dosage: bolus
Start date: 2009-05-27
End date: 2009-09-01
Fluorouracil
Dosage: 7 cycles
Indication: Colorectal Cancer Metastatic
Start date: 2009-01-28
End date: 2009-05-13
Fluorouracil
Folinic Acid
Start date: 2009-05-27
End date: 2009-09-01
Folinic Acid
Dosage: 7 cycles
Indication: Colorectal Cancer Metastatic
Start date: 2009-01-28
End date: 2009-05-13
Folinic Acid
Irinotecan Hydrochloride
Indication: Colorectal Cancer Metastatic
Start date: 2010-01-01
Oxaliplatin
Start date: 2008-06-01
End date: 2008-06-01
Oxaliplatin
Dosage: 7 cycles
Oxaliplatin
Oxaliplatin
Oxaliplatin
Start date: 2009-05-13
End date: 2009-05-13
Oxaliplatin
Indication: Colorectal Cancer Metastatic
Oxaliplatin
Start date: 2008-12-18
End date: 2008-12-18
Oxaliplatin
Oxaliplatin
Dosage: dose lowered
Oxaliplatin
Xeloda
Administration route: Oral
Xeloda
Dosage: two cycles
Administration route: Oral
Indication: Colorectal Cancer Metastatic
Start date: 2008-12-18
End date: 2009-01-07
Xeloda
Administration route: Oral
Xeloda
Dosage: two tablets in morning
Administration route: Oral
Other drugs received by patient: Dexamethasone; Zofran; Prilosec
Page 1 Next >>
|